• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

世界生物精神病学协会联盟(WFSBP)基层医疗中单相抑郁症生物治疗指南

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care.

作者信息

Bauer Michael, Bschor Tom, Pfennig Andrea, Whybrow Peter C, Angst Jules, Versiani Marcio, Möller Hans-Jürgen

机构信息

University Hospital Carl Gustav Carus, Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany.

出版信息

World J Biol Psychiatry. 2007;8(2):67-104. doi: 10.1080/15622970701227829.

DOI:10.1080/15622970701227829
PMID:17455102
Abstract

These practical guidelines for the biological treatment of unipolar depressive disorders in primary care settings were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). They embody the results of a systematic review of all available clinical and scientific evidence pertaining to the treatment of unipolar depressive disorders and offer practical recommendations for general practitioners encountering patients with these conditions. The guidelines cover disease definition, classification, epidemiology and course of unipolar depressive disorders, and the principles of management in the acute, continuation and maintenance phase. They deal primarily with biological treatment (including antidepressants, other psychopharmacological and hormonal medications, electroconvulsive therapy, light therapy).

摘要

这些关于基层医疗环境中单相抑郁障碍生物治疗的实用指南,由世界生物精神病学协会联合会(WFSBP)的一个国际特别工作组制定。它们体现了对所有与单相抑郁障碍治疗相关的现有临床和科学证据进行系统综述的结果,并为诊治此类患者的全科医生提供了实用建议。这些指南涵盖了单相抑郁障碍的疾病定义、分类、流行病学和病程,以及急性期、巩固期和维持期的治疗原则。它们主要涉及生物治疗(包括抗抑郁药、其他精神药理和激素类药物、电休克治疗、光疗)。

相似文献

1
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care.世界生物精神病学协会联盟(WFSBP)基层医疗中单相抑郁症生物治疗指南
World J Biol Psychiatry. 2007;8(2):67-104. doi: 10.1080/15622970701227829.
2
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder.世界生物精神病学协会联盟(WFSBP)单相抑郁障碍生物治疗指南,第1部分:重度抑郁症的急性和延续性治疗
World J Biol Psychiatry. 2002 Jan;3(1):5-43. doi: 10.3109/15622970209150599.
3
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders.世界生物精神病学学会联合会(WFSBP)单相抑郁障碍的生物学治疗指南,第 1 部分:单相抑郁障碍的急性和维持治疗更新 2013 年版。
World J Biol Psychiatry. 2013 Jul;14(5):334-85. doi: 10.3109/15622975.2013.804195. Epub 2013 Jul 3.
4
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions.世界生物精神病学协会联盟(WFSBP)单相抑郁障碍生物治疗指南,第2部分:重度抑郁症的维持治疗以及慢性抑郁症和阈下抑郁症的治疗。
World J Biol Psychiatry. 2002 Apr;3(2):69-86. doi: 10.3109/15622970209150605.
5
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.21 种抗抑郁药治疗成人重度抑郁症的急性治疗的疗效和可接受性比较:系统评价和网络荟萃分析。
Lancet. 2018 Apr 7;391(10128):1357-1366. doi: 10.1016/S0140-6736(17)32802-7. Epub 2018 Feb 21.
6
Psychological therapies for treatment-resistant depression in adults.成人难治性抑郁症的心理治疗
Cochrane Database Syst Rev. 2018 May 14;5(5):CD010558. doi: 10.1002/14651858.CD010558.pub2.
7
Antidepressants for the treatment of depression in people with cancer.用于治疗癌症患者抑郁症的抗抑郁药。
Cochrane Database Syst Rev. 2018 Apr 23;4(4):CD011006. doi: 10.1002/14651858.CD011006.pub3.
8
Better practices in collaborative mental health care: an analysis of the evidence base.协作式精神卫生保健的更佳实践:基于证据的分析
Can J Psychiatry. 2006 May;51(6 Suppl 1):7S-72S.
9
Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.氯胺酮和其他谷氨酸受体调节剂治疗单相重性抑郁障碍成人患者的抑郁症。
Cochrane Database Syst Rev. 2021 Sep 12;9(9):CD011612. doi: 10.1002/14651858.CD011612.pub3.
10
Newer generation antidepressants for depressive disorders in children and adolescents.用于儿童和青少年抑郁症的新一代抗抑郁药。
Cochrane Database Syst Rev. 2012 Nov 14;11(11):CD004851. doi: 10.1002/14651858.CD004851.pub3.

引用本文的文献

1
Medication reference tables for neurologists: A focus on psychotropic medications in epilepsy.神经科医生用药参考表:聚焦癫痫中的精神药物
Epilepsy Behav Rep. 2025 Mar 14;30:100760. doi: 10.1016/j.ebr.2025.100760. eCollection 2025 Jun.
2
The involvement of K channels in depression and pharmacological effects of antidepressants on these channels.钾通道与抑郁症的关系以及抗抑郁药对这些通道的药理作用。
Transl Psychiatry. 2024 Oct 2;14(1):411. doi: 10.1038/s41398-024-03069-6.
3
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study.
教育对精神分裂症和重度抑郁症治疗指南的影响以及对精神科医生催眠药物处方行为的影响:一项多中心研究。
BMC Psychiatry. 2024 May 29;24(1):399. doi: 10.1186/s12888-024-05816-x.
4
Basmisanil, an α5-GABAR negative allosteric modulator, produces rapid and sustained antidepressant-like responses in male mice.巴米沙尼,一种 α5-GABAR 负变构调节剂,可在雄性小鼠中产生快速和持续的抗抑郁样反应。
Neurosci Lett. 2024 Jun 11;833:137828. doi: 10.1016/j.neulet.2024.137828. Epub 2024 May 19.
5
Cool the Inflamed Brain: A Novel Anti-inflammatory Strategy for the Treatment of Major Depressive Disorder.冷却发炎的大脑:治疗重度抑郁症的一种新的抗炎策略。
Curr Neuropharmacol. 2024;22(5):810-842. doi: 10.2174/1570159X21666230809112028.
6
A factor analytic comparison of three commonly used depression scales (HAMD, MADRS, BDI) in a large sample of depressed inpatients.在一个大型抑郁症住院患者样本中,对三种常用抑郁量表(HAMD、MADRS、BDI)进行因子分析比较。
BMC Psychiatry. 2023 Jul 28;23(1):548. doi: 10.1186/s12888-023-05038-7.
7
Baseline depressive symptoms as predictors of efficacy and tolerability of the treatment with duloxetine: a network analysis approach.基线抑郁症状作为度洛西汀治疗疗效和耐受性的预测指标:一种网络分析方法
Front Psychiatry. 2023 Jun 16;14:1210289. doi: 10.3389/fpsyt.2023.1210289. eCollection 2023.
8
The Development of GABAergic Network in Depression in Recent 17 Years: A Visual Analysis Based on CiteSpace and VOSviewer.近17年抑郁症中γ-氨基丁酸能网络的发展:基于CiteSpace和VOSviewer的可视化分析
Front Psychiatry. 2022 May 18;13:874137. doi: 10.3389/fpsyt.2022.874137. eCollection 2022.
9
Primary Outcomes for Adults Receiving the Unified Protocol after Hurricane Harvey in an Integrated Healthcare Setting.飓风哈维后在综合医疗环境下接受统一方案治疗的成年人的主要结局。
Community Ment Health J. 2022 Nov;58(8):1522-1534. doi: 10.1007/s10597-022-00967-1. Epub 2022 Apr 4.
10
An End-to-End Depression Recognition Method Based on EEGNet.一种基于EEGNet的端到端抑郁症识别方法。
Front Psychiatry. 2022 Mar 11;13:864393. doi: 10.3389/fpsyt.2022.864393. eCollection 2022.